Pipeline

Pre-Clinical
Phase 1a/1b
Phase 2
Phase 3
Register
Tivantinib C-MET
METIV-HCC Trial (West)
Tivantinib C-MET
JET-HCC Trial (Japan)
ARQ 087 FGFR
Intrahepatic Cholangiocarcinoma (iCCA)
ARQ 087 FGFR
Solid Tumors
ARQ 092 AKT
Solid Tumors/Lymphoma/Endometrial cancer
ARQ 092 AKT
Proteus syndrome
ARQ 092 AKT
Other Rare Diseases
ARQ 751 AKT
Oncology/Rare Diseases
ARQ 761 NQ01
Solid Tumors/Pancreatic Cancer

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300